Volgen
Barbara L. Parsons
Barbara L. Parsons
Research Microbiologist, National Center for Toxicological Research, US FDA
Geverifieerd e-mailadres voor fda.hhs.gov
Titel
Geciteerd door
Geciteerd door
Jaar
Nucleotide sequences from the adenovirus-2 genome.
TR Gingeras, D Sciaky, RE Gelinas, J Bing-Dong, CE Yen, MM Kelly, ...
Journal of Biological Chemistry 257 (22), 13475-13491, 1982
3461982
Accumulation of wound-inducible ACC synthase transcript in tomato fruit is inhibited by salicylic acid and polyamines
N Li, BL Parsons, D Liu, AK Mattoo
Plant Molecular Biology 18, 477-487, 1992
2591992
Genotypic selection methods for the direct analysis of point mutations
BL Parsons, RH Heflich
Mutation Research/Reviews in Mutation Research 387 (2), 97-121, 1997
1841997
Spontaneous deletions and duplications of sequences in the genome of cowpox virus.
DJ Pickup, BS Ink, BL Parsons, W Hu, WK Joklik
Proceedings of the National Academy of Sciences 81 (21), 6817-6821, 1984
1531984
Many different tumor types have polyclonal tumor origin: evidence and implications
BL Parsons
Mutation Research/Reviews in Mutation Research 659 (3), 232-247, 2008
1282008
Fixation and spread of somatic mutations in adult colonic epithelium
A Nicholson, C Olpe, A Hoyle, AS Thorsen, T Rus, M Colombe, ...
Cell Stem Cell 22, 909-918, 2018
1092018
Evaluation of clonal origin of malignant mesothelioma
S Comertpay, S Pastorino, M Tanji, R Mezzapelle, O Strianese, ...
Journal of translational medicine 12, 1-9, 2014
972014
Multiclonal tumor origin: Evidence and implications
BL Parsons
Mutation research/reviews in mutation research 777, 1-18, 2018
602018
Personalized cancer treatment and the myth of KRAS wild-type colon tumors
BL Parsons, MB Myers
Discovery medicine 15 (83), 259-267, 2013
512013
Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR
PB McKinzie, BL Parsons
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 517 (1-2 …, 2002
512002
ACB-PCR quantification of K-RAS codon 12 GAT and GTT mutant fraction in colon tumor and non-tumor tissue
BL Parsons, KE Marchant-Miros, RR Delongchamp, TL Verkler, ...
Cancer investigation 28 (4), 364-375, 2010
492010
Breast cancer heterogeneity examined by high-sensitivity quantification of PIK3CA, KRAS, HRAS, and BRAF mutations in normal breast and ductal carcinomas
MB Myers, M Banda, KL McKim, Y Wang, MJ Powell, BL Parsons
Neoplasia 18 (4), 253-263, 2016
452016
K-RAS mutation in the screening, prognosis and treatment of cancer
BL Parsons, F Meng
Biomarkers in medicine 3 (6), 757-769, 2009
452009
MED1: a central molecule for maintenance of genome integrity and response to DNA damage
BL Parsons
Proceedings of the National Academy of Sciences 100 (25), 14601-14602, 2003
422003
Allele-specific competitive blocker-PCR detection of rare base substitution
BL Parsons, PB McKinzie, RH Heflich
Molecular Toxicology Protocols, 235-245, 2005
402005
Detection of a mouse H-ras codon 61 mutation using a modified allele-specific competitive blocker PCR genotypic selection method
BL Parsons, RH Heflich
Mutagenesis 13 (6), 581-588, 1998
401998
Transcription of orthopoxvirus telomeres at late times during infection
BL Parsons, DJ Pickup
Virology 175 (1), 69-80, 1990
401990
Detection of basepair substitution mutation at a frequency of 1 × 10−7 by combining two genotypic selection methods, MutEx enrichment and allele‐specific …
BL Parsons, RH Heflich
Environmental and molecular mutagenesis 32 (3), 200-211, 1998
391998
Measurement of tumor-associated mutations in the nasal mucosa of rats exposed to varying doses of formaldehyde
F Meng, E Bermudez, PB McKinzie, ME Andersen, HJ Clewell III, ...
Regulatory Toxicology and Pharmacology 57 (2-3), 274-283, 2010
382010
Evaluation of MutS as a tool for direct measurement of point mutations in genomic DNA
BL Parsons, RH Heflich
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 374 (2 …, 1997
381997
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20